Management of Sexual Partners in Syphilis Cases

Partner Management Algorithm Based on Exposure Timing

• The Centers for Disease Control and Prevention recommends presumptive treatment for sexual partners of patients with syphilis who were exposed within 90 days prior to diagnosis, even if they are seronegative, as they might be infected but not yet showing serologic evidence of disease 1, 2
• For partners exposed within 90 days of diagnosis, presumptive treatment should be administered immediately, even if serologic tests are negative, as early infection may not produce detectable antibodies 3, 4
• The recommended treatment is benzathine penicillin G 2.4 million units IM in a single dose, the same as for primary and secondary syphilis 1, 2

Considerations for Different Stages of Syphilis

• For primary syphilis, the Centers for Disease Control and Prevention recommends identifying and evaluating partners from the 3 months plus duration of symptoms before treatment 1, 2
• For secondary syphilis, identifying and evaluating partners from the 6 months plus duration of symptoms before treatment is recommended 1, 2
• For early latent syphilis, identifying and evaluating partners from 1 year before treatment is advised 1, 2

Clinical Rationale for Presumptive Treatment

• Early treatment prevents progression to later stages of disease that can cause significant morbidity and mortality, according to the Centers for Disease Control and Prevention 1, 2

Important Caveats and Pitfalls

• The Centers for Disease Control and Prevention advises against using serologic titers alone to differentiate early from late latent syphilis for determining treatment approach 1, 2
• All patients with syphilis and their partners should be tested for HIV, as co-infection is common, recommends the Centers for Disease Control and Prevention 1, 2
• The Jarisch-Herxheimer reaction may occur within 24 hours of treatment and patients should be advised of this possibility, according to the Centers for Disease Control and Prevention 1, 2

Prophylactic Treatment for Syphilis Exposure

Treatment Regimen

• The Centers for Disease Control and Prevention (CDC) recommends benzathine penicillin G 2.4 million units IM in a single dose as the first-line prophylactic treatment for syphilis exposure, providing adequate treponemicidal blood levels and preventing progression to symptomatic disease in individuals without penicillin allergy 5, 6
• The single-dose regimen of benzathine penicillin G is the recommended prophylactic treatment, identical to the regimen used for primary and secondary syphilis, according to the CDC 5, 6

Alternative Regimens

• For individuals with penicillin allergy, the CDC recommends doxycycline 100 mg orally twice daily for 2 weeks as an alternative regimen 5, 6
• Tetracycline 500 mg orally four times daily for 2 weeks is an alternative regimen for individuals with penicillin allergy, though compliance is typically better with doxycycline 5, 6
• Erythromycin 500 mg orally four times daily for 2 weeks is a less effective alternative regimen and should only be used when compliance can be assured 5, 6

Critical Follow-Up Requirements

• The CDC recommends repeat serologic testing (RPR or VDRL) at 6, 12, and 24 weeks after exposure, as initial negative tests do not exclude early infection 7
• All patients with syphilis exposure should be tested for HIV, as co-infection is common, according to the CDC 8

Partner Treatment Timing and Regimens for Syphilis Exposure

Immediate Presumptive Treatment (≤ 90 Days Since Exposure)

• For sexual partners exposed within 90 days of a patient diagnosed with primary, secondary, or early latent syphilis, the CDC recommends immediate presumptive treatment with a single intramuscular dose of benzathine penicillin G 2.4 million units, even if the partner’s serologic test is negative. 9

Treatment Strategy for Exposures > 90 Days

• When exposure occurred more than 90 days before the index case’s diagnosis and serologic results are unavailable or follow‑up cannot be guaranteed, the CDC advises presumptive treatment of the partner. 9
• If reliable serologic testing and assured follow‑up are available for exposures > 90 days, the CDC recommends basing treatment decisions on the partner’s test results. 9

Partner Identification Periods by Stage of Index Patient

• Primary syphilis: Identify and evaluate partners from 3 months prior to symptom onset up to the time of treatment. 9
• Secondary syphilis: Identify and evaluate partners from 6 months prior to symptom onset up to the time of treatment. 9
• Early latent syphilis: Identify and evaluate partners from 1 year before the patient’s treatment date. 9

Management of Patients with High Nontreponemal Titers

• For patients with syphilis of unknown duration who have a nontreponemal titer ≥ 1:32, the CDC advises assuming early syphilis for partner‑notification purposes and applying the early‑syphilis presumptive‑treatment algorithm to their partners. 9

Evaluation of Long‑Term Partners of Latent Syphilis Cases

• Long‑term sexual partners of individuals with latent syphilis should undergo clinical and serologic evaluation, and treatment should be guided by those findings rather than by presumptive therapy. 9

Recommended Treatment Regimens for Partners

• First‑line: Benzathine penicillin G 2.4 million units IM as a single dose (CDC recommendation). 9
• Penicillin‑allergic partners: Doxycycline 100 mg orally twice daily for 14 days (alternative regimen). 9

Follow‑Up Serologic Testing

• All treated partners must have repeat non‑treponemal serologic testing (RPR or VDRL) at 6, 12, and 24 weeks after exposure, because an initial negative test does not exclude early infection. 9

HIV Testing Requirement

• The CDC mandates HIV testing for all patients with syphilis and their sexual partners, given the high rate of co‑infection and its impact on management. 9

Jarisch‑Herxheimer Reaction Counseling

• The CDC recommends counseling partners before treatment about the possibility of a Jarisch‑Herxheimer reaction—an acute febrile illness with headache and myalgia that can occur within 24 hours of therapy. 9
• Antipyretics may relieve symptoms but do not prevent the reaction; treatment should not be delayed, even in pregnant partners, despite the risk of precipitating early labor or fetal distress. 9